The company’s platform, OncoGaze, analyzes genomic biomarkers from routine clinical slides to help clinicians select ...
Microplastics scientists are finding the tiny particles everywhere, even in their own research laboratories. So how do they ...
Parse Biosciences, a QIAGEN company and the leading provider of scalable and accessible single-cell sequencing solutions, today announced the commercial availability of Evercode (TM) Whole ...
Illustration by Klawe Rzeczy for TIME. Source images: Bhawika Chhabra—Reuters (Amodei); Yoan Valat—Pool/AFP/Getty Images (Trump); Aaron Ontiveroz—The Denver Post/Getty Images (Hegseth); J. David ...
Pulp and tissue company Domtar Tuesday announced it will indefinitely idle operations at its Coosa Pines fluff pulp mill in May. The decision will impact 285 employees, the company said. The mill on ...
Accelerating development of next-generation cancer testing using 3D cell culture technology within the Texas Medical Center, ...
Vaxess Technologies today announced a rebranding to Terrestrial Bio, Inc., along with $50 million in Series C financing.
The firm validated its test for one new indication in 64 patients with a variety of solid tumors, including breast, ovarian, melanoma, and head and neck cancers.
The acquisition expands Merit’s portfolio of therapeutic oncology products dedicated to the accurate diagnosis and localization of breast and soft tissue tumors.
AutoCanada, Inc. engages in the operation of franchised automobile dealerships. It operates through the Canada and United States geographical segment. The firm offers a range of automotive products ...